TORONTO, July 3, 2026, 13:09 (EDT)
- AtkinsRéalis Group Inc. (TSE:ATRL) was up 4.81% at C$91.87 as of 12:52 p.m. EDT, beating the S&P/TSX Composite’s 0.87% rise.
- The stock’s one-day jump tacked on roughly C$683 million in equity value, about 93% of its Q1 nuclear revenue.
- Turkey’s initial look at CANDU reactors, not any firm contract, kicked off the trade. Ankara is still talking nuclear with Rosatom, KEPCO, and SPIC.
- TSX traded on July 3. TMX’s holiday calendar had Canada Day on July 1.
AtkinsRéalis Group Inc. (TSE:ATRL) rose 4.81% to C$91.87 in Toronto on Friday as Reuters said Turkey is set to finish an early review of the company’s CANDU reactors after an info exchange later this summer. Google Finance showed shares up C$4.22 at 12:52 p.m. EDT. The company has 161.92 million shares out and a market cap of C$14.88 billion.
The trade outpaced the market. The S&P/TSX Composite Index was up 0.87% to 35,271.48 just before 1 p.m. EDT. Earlier, Reuters said Canada’s main index had gained 1% with gold and mining stocks up. TMX’s 2026 holiday calendar shows Canada Day on July 1, not July 3, for the Canadian market holiday.
| Security / index | Quote time | Price / level | 1-day move |
|---|---|---|---|
| AtkinsRéalis Group Inc. (TSE:ATRL) | 12:52 EDT | C$91.87 | up 4.81% |
| WSP Global Inc. (TSE:WSP) | 12:51 EDT | C$180.48 | added 1.91% |
| Stantec Inc. (TSE:STN) | 12:49 EDT | C$100.37 | gained 1.19% |
| Aecon Group Inc. (TSE:ARE) | 12:53 EDT | C$51.26 | rose 3.53% |
| S&P/TSX Composite Index | 12:49 EDT | 35,271.48 | up 0.87% |
AtkinsRéalis stood out as the clean Turkey nuclear play among the names. Aecon gained more than the rest but that was tied to separate construction headlines on Google Finance. The Friday move for AtkinsRéalis came on news about CANDU export talks. WSP, Stantec, and Aecon all lagged AtkinsRéalis on percentage change on Google Finance at roughly the same point.
AtkinsRéalis saw its equity value jump by around C$683 million in one session, based on a C$4.22 move per share and Google Finance’s share count. That’s the figure that traders paid attention to. The surge is close to a quarter’s worth of nuclear sales, even though Turkey hasn’t signed a deal.
| Measure | Amount | Investor read |
|---|---|---|
| Intraday stock gain | +C$4.22/share | Accounted for most of Friday’s market-cap jump |
| Shares outstanding | 161.92 million | Figure used to calculate equity value |
| Implied equity value added | ~C$683 million | Market’s tab for Turkey exposure |
| Q1 nuclear revenue | C$736.6 million | Share gain matches about 93% of this sales number |
| Total Q1 revenue | C$3.0 billion | Nuclear segment made up around a quarter of revenue |
| Q1 backlog | C$20 billion | Backlog base sits above Turkey numbers |
AtkinsRéalis executive vice president Gary Rose told Reuters the firm is supplying Turkey’s state plant operator TUNAS with information needed for a report due this summer. “We’ve got five working teams,” Rose said. Reuters reported the review might open the way for direct talks on a nuclear plant bid once the information is shared. Reuters
Turkey already has its first nuclear plant under construction — a $20 billion, 4.8 GW project with Russia’s Rosatom, according to Reuters. The government is also in talks with South Korea’s KEPCO and China’s SPIC for two more plants. But Reuters said Turkey is still short 2.4 GW on its 2035 interim nuclear target.
AtkinsRéalis said in March it signed a memorandum of understanding with TUNAS. The two said they would look at CANDU technologies for Turkish locations and review regulatory, licensing, finance and delivery models. No contract value was included in the release.
Nuclear is already driving results at AtkinsRéalis. First-quarter nuclear revenue jumped 36.8% to a record C$736.6 million. Total revenue was up 17.8% at C$3.0 billion. Backlog finished the quarter at C$20 billion. CEO Ian L. Edwards said in May: “demand for our unique capabilities remains strong.” AtkinsRéalis
Analysts’ targets are still above where shares closed Friday. Investing.com lists a 12-month average target of C$114.53, with the highest at C$131 and the lowest at C$99. There are 15 buys and no sells shown. That puts the average target about 25% over the C$91.87 price on Google Finance.
Investors face a timing risk here. The shares already price in hope for an export deal, but there’s no word yet on a Turkey bid, contract size, or award timing in anything public. AtkinsRéalis reports July 30, per Investing.com, which will put nuclear margins and backlog conversion under the microscope for anyone betting on the Turkey angle.
